Wordt geladen...
Involvement of Patient Organisations in Research and Development of Orphan Drugs for Rare Diseases in Europe
Patients’ representatives have an increasingly present voice in all aspects of drug development from fundamental research through regulatory processes to health technology assessment. Although major advances have been made in raising awareness and increasing funding for rare diseases, important chal...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
S. Karger AG
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3531929/ https://ncbi.nlm.nih.gov/pubmed/23293582 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000342758 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|